pharma · Cystic Fibrosis (CF) · Accidental Hypothermia · SION
Sionna Therapeutics
Sionna Therapeutics is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker SION. Primary therapeutic focus areas include Cystic Fibrosis (CF), Accidental Hypothermia, Bleeding, End-stage Ki
Boston, USA HQ
2019 Founded
74 Employees
Public company Type
SION · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2019
- Employees
- 74
- Programs
- 5
- Drugs
- 4
- Patents
- 0
SION-719
Phase 2 · small molecule · Cystic Fibrosis (CF)
SION-719 for Cystic Fibrosis (CF) is a Phase 2 program (small_molecule) at Sionna Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code SION-719-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sionna Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cystic Fibrosis (CF)
- Status
- active
- Trials
- 1